Marketresearchnews

Tuesday, 20 November 2018

Anti-Hypertensive Drugs Market Segmentation Detailed Study with Forecast Up To 2018

Anti-hypertensive drugs are used to treat hypertension (high blood pressure). Hypertension is a state of chronic elevated arterial blood pressure at or greater than 140/90 mm Hg for adults.

The global anti-hypertensive drugs market was valued at $32.2 billion in 2015, and is expected to reach $ 38.9 billion by 2022. Thus the market is expected to perform sluggish growth at a CAGR of 2.73% from 2016 to 2022.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2347

There exact cause of essential hypertension is unknown but is blamed on unhealthy lifestyle and ageing. The major market driving factor for secondary hypertension are greater detection and early diagnosis. Rise in the prevalence diseases such as kidney problems, thyroid problems, adrenal gland tumors, heart ailments, chronic alcohol use etc. in which anti-hypertensive are used are some of the other factors driving the growth of the market.

The constraints however are overwhelming and include patent expiries such as Actelion's Tracleer (2015), and United Therapeutic's Remodulin (2014). Other blockbuster’s such as Novartis's Diovan and Exforge, Sanofi Aventis's Avapro (2012) etc are also off-patent.

Key Players

Novartis AG

Daiichi Sankyo Company Limited

Acetelion Ltd

Boehringer Ingelheim

Sanofi S.A.

Astra Zeneca plc

Ranbaxy Laboratories Limited, Inc.

Takeda Pharmaceuticals Company Limited

Pfizer Inc.

Segments:

Global anti-hypertensive drugs market has been segmented on the basis of pharmacological class, hypertension type, disease source and Region.

Regional Analysis

Globally North America is the largest market for global anti-hypertensive drugs. Europe is the second-largest market for global anti-hypertensive drugs. The near future market for anti-hypertensive drugs will be dominated by the developed regions with developing regions providing a supporting role only. However the developing regions market particularly Asia Pacific will be the fastest growing and is likely to be the key to the future.

Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/anti-hypertensive-drugs-market-2347

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s Five Forces Model

4.1.1 Bargaining Power Of Suppliers

4.1.2 Bargaining Power Of Customer

4.1.3 Intensity Of Competitor’s

4.1.4 Threat Of New Entrants

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Latest Study Offers Detailed Insights on Dental Consumables Market 2018

Market Scenario:

Dental Consumables are a category of products that are used on patients by dental practitioners or dentists in order to treat and /or perform procedures associated with preventive, restorative, diagnostic and emergency oral health issues.

Dentistry is one of the oldest professions dating back to 7000 B.C. however it was not until the 1700s that it became a more defined profession. Dental consumables industry has thus flourished as a result of the overall advances in the dentistry techniques adopted and practiced by dental professionals worldwide.

The various repairs and preventive cares associated with oral health of the ever growing population worldwide have consistently added to the growth of the dental consumables market globally. Dentistry as a branch has also further evolved and developed its sub branches resulting in specialist oral care depending upon the type of treatment required for the oral care. Major specializations include Endodontics, Orthodontics, Periodontics and Prosthodontics. Other specializations include professionals as Maxillofacial Surgeons, Pedodontist, Cosmetic/Aesthetic Dentist, and General Dentist. All these specializations more or less require the same kind of dental instruments, but most of their materials and other instruments may vary depending upon the treatment carried out.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1806

Globally the market for Dental Consumables is growing steadily and has a bright future. The market for Dental Consumables is expected to grow at the CAGR of ~ 6.5% from 2016 to 2024.

Segments:

Dental Consumables market has been segmented on the basis of types which comprises of Dental Implants, Dental Prosthetics, Dental Restorative Material, Dental Regenerative Material and Others.

Regional Analysis

Globally Europe is the largest market for Dental Consumables. North America is expected to be the second-largest market and furthermore Asia pacific market is expected to be the fastest growing market for Dental Consumables.

Key Players

Some of the key players in this market are: Septodont, 3M, Straumann, Henry Schein, KERR Corporation, GC orthodontics, EnvisionTEC, Patterson Dental, American Orthodontics, Planmeca OY, Dentsply Sirona, Nobel Biocare (Part of danaher corporation)

Browse Complete 110 Pages Premium Research Report Enabled with 113 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/dental-consumables-market-1806

Detailed Table of Contents:

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Demand & Supply – Gap Analysis

… Continued!

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Pacemaker Market 2018 - Opportunity, Driving Trends and deep study 2023

Market Scenario:

The global pacemaker market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global pacemaker market is expected to grow at a CAGR ~6.5 % during the forecast period of 2018–2023.

A pacemaker is a small device that consists of a pulse generator which has a battery and a tiny computer circuit and pacing leads. This device is used to treat Atrial Fibrillation (AF).

The increasing prevalence of cardiac diseases and growing geriatric population are propelling the growth of this market. The management of atrial fibrillation in the old age population is complex due to altered pharmacology, competing comorbidities, limited life expectancy, frailty, and varied treatment goals. According to a 2018 study published in the Aging Medicine, the prevalence of atrial fibrillation is estimated to be 0.3% in 40 years old patients, 5 to 9% in between 60-80 years old patients, and nearly 10% of patients more than 80 years old.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1587

Furthermore, raising awareness about awareness about cardiovascular disorders, and technological advancements in cardiac pacemakers boosts the growth of the global pacemaker market.

However, the complications associated with the implant and the high cost of pacemakers may hinder the growth of the market during the forecast period.

Segmentation

The global pacemaker market is segmented on the basis of the product type, application, implant approach, end-user, and region.

On the basis of the product type, the market is classified as implantable, and external. The implantable segment is further sub-segmented as a single chamber, dual chamber, and biventricular.

On the basis of the application, the market is segmented into bradycardia, heart failure, hypertrophic cardiomyopathy, syncope, and others. The bradycardia segment is further sub-segmented as sinus node dysfunction, and AV block.

On the basis of the implant approach, the market is segmented as endocardial approach and epicardial approach.

On the basis of end-user, the market is segmented as hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.

Geographically, the global pacemaker market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American pacemaker market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.

The Europe pacemaker market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the U.K., Italy, Spain, and the Rest of Western Europe.

The Asia Pacific pacemaker market is segmented into Japan, China, India, Republic of Korea, Australia, and the Rest of Asia Pacific.

The Middle Eastern and African pacemaker market is segmented into the Middle East and Africa.

Regional Market Summary

The American region holds the major share of the global pacemaker market, owing to the existing well-established healthcare system, growing geriatric population, and technological advancements. For instance, in November 2017, Medtronic plc received FDA approval for Azure pacemakers with BlueSync technology. The Azure XT pacemaker features the Medtronic Reactive ATP algorithm to slow the progression of atrial fibrillation in patients with implanted cardiac devices.

Europe holds the second position in the global pacemaker market. It is expected that the government support towards research & development expenditure and rising contribution of leading market players is likely to drive the European pacemaker market. The rising cases of cardiovascular diseases are continuously motivating marketers to come up with more advanced technology. In June 2017, BIOTRONIK launched Edora SR-T globally. Edora SR-T is the smallest MR conditional pacemaker with an automated MRI detection capability.

The Asia Pacific pacemaker market consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia Pacific. The rising prevalence of atrial fibrillation is propelling the growth of the market. In Asia, the prevalence of atrial fibrillation has been estimated to be 1%. It is also estimated that by 2050, 72 million individuals in Asia will be diagnosed with atrial fibrillation, i.e., more than double the combined numbers of patients in the U.S., and Europe.

The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.

Key Players

Medtronic Plc, Biotronik GmbH & Co. KG, Boston Scientific Corporation, St. Jude Medical Inc., ZOLL Medical Corporation, MEDICO S.p.A, Vitatron, Pacetronix, Cordis, Inc., Sorin Group, Edwards Lifesciences, General Electric Company, and Cook are some prominent players in this market.

Browse Complete 90 Pages Premium Research Report Enabled with 83 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/pacemaker-market-1587

Detailed Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

...Continued

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Monday, 19 November 2018

Retropharyngeal Abscess Market Revenue, Opportunity, Forecast and Value Chain 2018

Market Synopsis of Global Retropharyngeal Abscess Market:

Market scenario:

A retropharyngeal abscess is a serious infection, usually starts in the lymph nodes, characterised by collection of pus at the back of the throat. Retropharyngeal abscess typically occurs in children under the age of eight, sometimes it can also affect adults. The symptoms of retropharyngeal abscess include difficulty or noisy breathing, difficulty and pain while swallowing, drooling, severe cough, severe throat pain, neck stiffness or swelling, muscle spasms in the neck among others. Retropharyngeal abscess is generally preceded by upper respiratory infections mostly a middle ear or sinus infection.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4922

The causes of retropharyngeal abscess are trauma or injury, medical procedure, dental procedures, alcohol intake, diabetes, cancer, AIDS, weakened immune system or a chronic diseases such as tuberculosis and others. Other complications indicated are pneumonia, blood clots in the jugular vein, mediastinitis, osteomyelitis and others. If left untreated, retropharyngeal abscess infection can spread to other parts of the body resulting in septic shock and organ failure. In severe instances, a retropharyngeal abscess can lead to death. The most common bacteria involved are Streptococcus, Staphylococcus, and others. Other infections, such as HIV and tuberculosis can also cause the retropharyngeal abscess. Retropharyngeal abscess recurs in an estimated 1 to 5% of patients and such patients are 40 to 50% more likely to die due to abscess-related complications. Retropharyngeal abscess also slightly more common in males than females.

The market drivers for global retropharyngeal abscess market, are rise in demand due to the growing younger and susceptible population, increasing screening, urgency of the retropharyngeal abscess treatment, and rise in risk factors. The rise in cases of retropharyngeal abscess due to increase in Methicillin-resistant Staphylococcus aureus (MRSA) infections also stimulates the market. The market restraints are complications such as risk of bleeding, infections, pain, especially during surgery, high cost of retropharyngeal abscess treatment, lack of cardiac care infrastructure, and lack of focus on other diseases by the developing regions and others.

The global retropharyngeal abscess market is expected to reach USD 5.9 billion by 2023, and the market is projected to grow at a CAGR of ~ 4.5 % during the forecast period 2017-2023.

SegmentsThe global retropharyngeal abscess market has been segmented on the basis of diagnosis, treatment, and end user.

Based on the diagnosis, the market has been segmented as X-rays and computed tomography, blood tests, physical exam and others.

Based on the treatment, the market has been segmented as calcium antibiotics, pain killers, surgical drainage and others.

Based on the end user, the market has been segmented as hospitals and clinics, research and academics and others.

Regional AnalysisA significant market share of the global retropharyngeal abscess market is held by the Americas, owing to high expenditure on the health care especially in major countries of the region like the U.S. and Canada. Additionally, the number of cardiac procedures in the U.S and Canada is increasing due to greater healthcare penetration, which drives the retropharyngeal abscess market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of infective procedures treatment in the returns of hospitals favors the market. The large number of pharmaceutical companies in the U.S. is also a cause for the faster development of retropharyngeal abscess market in the US. The development of broad spectrum antibiotics in developed regions such as the U.S. and Europe is a strong driver of the market.

Europe is the second largest market in the world due to growing pharmaceutical industry and healthcare penetration. The European market growth is led by countries such as Germany and France. Germany is expected to be the fastest growing market over the assessment period due to its large pharmaceutical and microsurgery devices industry. The development of Methicillin-resistant Staphylococcus aureus (MRSA) especially in the southern regions of Europe such as Spain, Italy etc. stimulates the market.

Asia Pacific region is expected to grow rapidly; China and India are likely to lead this market due to fast growing healthcare sector and large unmet needs over the forecast period. South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth. The growing penetration of healthcare industry in the Asia Pacific region is expected to drive the future retropharyngeal abscess market in the region. However the low expenditure on healthcare coupled with the poor incomes in the developing regions is a dent on the market.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt and Iran. The African region is expected to witness a poor growth owing to poor economic and political conditions, and poor healthcare development. Other regions are expected to be laggards due to poor social development and tribal identities such as sub Saharan Africa.

Key Players in the Global Retropharyngeal abscess MarketSome of the key players profiled in the report are Merck KGaA, Johnson & Johnson, AstraZeneca plc, Sanofi S.A., Pfizer, Mylan N.V, Novartis AG, Teva pharmaceutical company, GlaxoSmithKline plc., and others.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4922

Detailed Table of Contents:

Table Of Contents

1. Introduction

1.1 Definition

1.2 Scope Of Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure:

2. Research Methodology

2.1 Research Process:

2.2 Primary Research

2.3 Secondary Research:

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

4. Market Factor Analysis

4.1 Porters Five Forces Model

4.2 Bargaining Power Of Suppliers

4.3 Bargaining Power Of Buyers

4.4 Threat Of New Entrants

4.5 Threat Of Substitutes

4.6 Intensity Of Rivalry

...Continued

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com